Drug Type Chemical drugs |
Synonyms |
Target |
Action inhibitors, antagonists |
Mechanism NTRK inhibitors(Neurotrophic tyrosine kinase receptor inhibitors), VEGFR antagonists(Vascular endothelial growth factor receptor antagonists), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gastrointestinal Neoplasms | IND Approval | United States | 29 Dec 2023 | |
| Neoplasms | Preclinical | China | 02 Feb 2021 |





